EMFAT
Emerald Mutual Fund Advisers Trust’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-82,212
| Closed | -$3.78M | – | 273 |
|
|
2017
Q2 | $3.78M | Sell |
82,212
-140,400
| -63% | -$6.46M | 0.16% | 152 |
|
|
2017
Q1 | $9.64M | Hold |
222,612
| – | – | 0.44% | 78 |
|
|
2016
Q4 | $8.62M | Sell |
222,612
-62,178
| -22% | -$2.41M | 0.41% | 88 |
|
|
2016
Q3 | $14.4M | Buy |
284,790
+19,399
| +7% | +$982K | 0.73% | 50 |
|
|
2016
Q2 | $12.1M | Sell |
265,391
-31,392
| -11% | -$1.43M | 0.68% | 53 |
|
|
2016
Q1 | $11.7M | Buy |
296,783
+645
| +0.2% | +$25.5K | 0.66% | 60 |
|
|
2015
Q4 | $16.8M | Buy |
296,138
+27,000
| +10% | +$1.53M | 0.88% | 34 |
|
|
2015
Q3 | $10.7M | Sell |
269,138
-39,540
| -13% | -$1.57M | 0.7% | 53 |
|
|
2015
Q2 | $14.7M | Sell |
308,678
-38,949
| -11% | -$1.86M | 1.14% | 21 |
|
|
2015
Q1 | $13.1M | Sell |
347,627
-107,230
| -24% | -$4.05M | 1.08% | 25 |
|
|
2014
Q4 | $10.2M | Buy |
454,857
+150,948
| +50% | +$3.37M | 0.88% | 43 |
|
|
2014
Q3 | $4.76M | Buy |
303,909
+44,546
| +17% | +$698K | 0.46% | 80 |
|
|
2014
Q2 | $3.85M | Buy |
259,363
+20,803
| +9% | +$309K | 0.35% | 97 |
|
|
2014
Q1 | $3.84M | Buy |
+238,560
| New | +$3.84M | 0.37% | 93 |
|